• Skip to primary navigation
  • Skip to main content
Finnish Society of Gene and Cell Therapy

FSGCT

Finnish Society of Gene and Cell Therapy

  • Home
  • About Us
    • About Us
    • Board
    • President’s message 
    • GDPR statement
  • Events and news
    • News
    • Events
    • Travel grants
  • Useful information
    • Gene and cell therapy societies
    • Further reading
  • Sponsors
  • Contact Us
    • Inform us about your event
  • Suomi
  • Show Search
Hide Search

Events and news

BSGCT Conference 2023

March 28, 2023

British Society for Gene and Cell Therapy (BSGCT) organises its annual conference in Stevenage Science Park on 22.-23. June 2023. The…

Continue Reading BSGCT Conference 2023

Gene therapy for Haemophilia B approved in Europe

March 7, 2023

HEMGENIX® (etranacogene dezaparvovec) has received a conditional marketing authorisation from the European Commission. UniQure, a company specialising in the development of…

Continue Reading Gene therapy for Haemophilia B approved in Europe

Finnish gene therapy for bladder cancer approved by FDA

January 5, 2023

Ferring Pharmaceuticals has announced that the novel gene therapy for bladder cancer developed by its sister company FinVector Oy has been…

Continue Reading Finnish gene therapy for bladder cancer approved by FDA

Registration for the ESGCT 28th Annual Congress is open

May 25, 2021

Registration and abstract submission portal for the European Society of Gene and Cell Therapy 28th Annual Congress in now open. The…

Continue Reading Registration for the ESGCT 28th Annual Congress is open

28th ESGCT Annual Congress postponed

September 21, 2020

28th European Society of Gene and Cell Therapy Annual Congress in Edinburgh will be postponed due to the COVID-19 pandemic. Next…

Continue Reading 28th ESGCT Annual Congress postponed

Annual congress 2020

June 2, 2020

Annual congress 2020 is organised by the parent organisation Europian Society of Gene and Cell Therapy in collaboration with BSGCT at…

Continue Reading Annual congress 2020

© Copyright 2020 Finnish Society of Gene and Cell Therapy · All Rights Reserved


Tietosuojakäytäntö · Privacy policy